iiinova — where your digital self keeps evolving

Unitaid @unitaid.bsky.social · 04/09/2026

Africa shouldn’t have to wait years for the next generation of HIV prevention. Unitaid is supporting manufacturers in Uganda, Kenya and South Africa to prepare for potential future production of alimatravir, a once-monthly HIV prevention pill now in Phase 3 development. ow.ly/gQNK50ZIakt

041

Unitaid @unitaid.bsky.social · 02/09/2026

“The decisions countries make now will shape the impact these innovations can deliver.” Unitaid is investing US$36M to build evidence for spatial emanators at scale and explore insecticide-treated baby wraps. ow.ly/FbXW50ZI98Y

000

Unitaid @unitaid.bsky.social · 20/08/2026

Malaria remains one of the clearest examples of unequal progress in global health. Africa accounts for 95% of deaths. A child still dies every minute. Progress is real where access expands, but no single tool is enough. Protection must be layered, sustained, and evolving. #WorldMosquitoDay

001

Unitaid @unitaid.bsky.social · 18/08/2026

US$36m to generate evidence for scaling up new malaria prevention tools Unitaid is funding projects led by Swiss TPH and CRID to generate evidence on spatial emanators and insecticide-treated baby wraps, helping inform country decisions and WHO guidance.

000

Unitaid @unitaid.bsky.social · 17/08/2026

Every minute, a child dies from malaria. As we look ahead, we recognise the progress made, and the need to stay ahead of resistance. No single intervention is enough. Layered approaches combining prevention, diagnosis and treatment are essential.

001

Unitaid @unitaid.bsky.social · 12/08/2026

Africa is entering a new era of pharmaceutical manufacturing, but regionally made medicines depend on trust. Bioequivalence provides evidence that generic medicines work just as safely and effectively as those already on the market.

001

Unitaid @unitaid.bsky.social · 11/08/2026

For malaria innovations, speed matters. The pathway from evidence to access for next-generation mosquito nets was reduced from 9 years to 3 years by aligning research, supply and procurement earlier. Faster access helps communities benefit sooner.

000

Unitaid @unitaid.bsky.social · 10/08/2026

For frontline health workers, every moment matters. In Kenya, Dr. Maureen Muchela shares how access to respiratory support is changing what is possible for premature and critically ill newborns.

000

Unitaid @unitaid.bsky.social · 06/08/2026

From prototype to scale. With support from Unitaid, Vayu’s bCPAP system moved from hand-built prototypes to a solution used in newborn care across Africa, Asia and Latin America. 500,000+ newborns and infants have now been treated globally.

000

Unitaid @unitaid.bsky.social · 28/07/2026

What does it take to turn innovation into equitable access? That was the conversation at our #AIDS2026 satellite session marking 20 years of Unitaid. It was a privilege to hear from longstanding partners who have helped shape our journey – and to look ahead at what comes next.

001

Unitaid @unitaid.bsky.social · 28/07/2026

Viral hepatitis claims 1.3 million lives every year. The tools exist. The challenge is access. Unitaid is supporting innovations that help make hepatitis prevention, testing and treatment simpler and more accessible. #WorldHepatitisDay

001

Unitaid @unitaid.bsky.social · 27/07/2026

A cure for hepatitis C exists. The next challenge is making sure care reaches everyone who needs it. A Unitaid-backed study led by Médecins du Monde in Armenia, Georgia and Tanzania is exploring how simpler approaches can accelerate access to hepatitis C treatment. Read more below.

020

Unitaid @unitaid.bsky.social · 26/07/2026

Latin America & the Caribbean helped shape the future of HIV prevention. But will they benefit from the innovations they helped advance? The region accounts for 1 in 10 new HIV infections globally, yet access to new innovations remains uneven. #AIDS2026. IAS - the International AIDS Society

151

Unitaid @unitaid.bsky.social · 24/07/2026

Innovation creates possibility. Preparation creates access. We're investing now to help African manufacturers prepare for the potential future production of investigational once-monthly HIV prevention pill alimatravir (MK-8527), pending successful trials and regulatory approval.

131

Unitaid @unitaid.bsky.social · 24/07/2026

#RethinkRebuildRise. The HIV response has transformed what is possible, but progress is not reaching everyone equally. At #AIDS2026, we’ll join the global community to discuss how innovation, partnership and access can shape the next chapter of the response. Find us: ow.ly/F8L350ZqH0k

012

Unitaid @unitaid.bsky.social · 24/07/2026

20 years. 150+ health products. 300 million people reached annually. US$10 billion in projected savings by 2030. Nearly 1 million additional lives saved. The next 20 years start now.

000

Unitaid @unitaid.bsky.social · 23/07/2026

Scientific breakthroughs only save lives when they reach communities. Ahead of #AIDS2026, we're investing an additional US$15M to support Global South-led partnerships and help countries prepare for the next generation of HIV prevention.

012

Unitaid @unitaid.bsky.social · 23/07/2026

Behind every health innovation is a human story. For 20 years, access to better medicines, diagnostics and prevention tools has helped change lives around the world.

000

Unitaid @unitaid.bsky.social · 22/07/2026

Children living with HIV were once treated with medicines designed for adults. Improving access meant creating treatments designed around children’s needs. Because everyone deserves medicines that work for them. #AIDS2026

000

Unitaid @unitaid.bsky.social · 22/07/2026

What does #oil have to do with #HIV medicines? More than you might think. Our latest analysis reveals a hidden vulnerability in pharmaceutical supply chains: oil price shocks could increase the cost of producing first-line HIV treatment by up to 44%.

011

Unitaid @unitaid.bsky.social · 22/07/2026

Resistance doesn't wait. To sustain progress against malaria and other diseases, innovation must move faster than the threats we face. Protecting gains requires constant vigilance and continued investment.

000

Unitaid @unitaid.bsky.social · 22/07/2026

Only 45% of newborns globally benefit from interventions to prevent hepatitis B transmission. Unitaid supports community-led approaches to help ensure mothers and babies are not left behind.

000

Unitaid @unitaid.bsky.social · 21/07/2026

HIV self-testing changed how we think about access. By removing barriers and giving people more choice, it helped reach communities who were being missed by traditional services. #AIDS2026

020

Unitaid @unitaid.bsky.social · 20/07/2026

20 years of HIV innovation. One lesson: Innovation creates possibility. Access creates impact. Ahead of #AIDS2026, we’re looking back at the partnerships and breakthroughs that transformed the HIV response, and what comes next.

011

Unitaid @unitaid.bsky.social · 20/07/2026

Ahead of #WorldHepatitisDay, we're highlighting the communities most affected by hepatitis C. People who inject drugs account for 43% of new infections. We support community-led approaches that bring testing and treatment closer to the people who need them.

000

Unitaid @unitaid.bsky.social · 17/07/2026

Innovation alone is not enough. Access creates impact. A promising innovation can stall if it is too expensive, unavailable or difficult to deliver. We work across the access journey to help ensure health innovations reach the people and communities who need them.

000

Unitaid @unitaid.bsky.social · 17/07/2026

Access is about far more than medicines. Anton Basenko shares how harm reduction changed his life, and why eliminating hepatitis C means removing barriers to care and working alongside communities.

000

Unitaid @unitaid.bsky.social · 17/07/2026

For many people with TB, the biggest barrier to diagnosis isn’t the technology, it’s access. Together with CHAI, we’ve reduced the cost of AI-powered TB screening software by up to 65%, helping countries expand access to faster diagnosis where radiologists are in short supply.

011

Unitaid @unitaid.bsky.social · 16/07/2026

Lenacapavir is a long-acting HIV prevention option with potential to transform prevention. Unitaid and partners have helped secure a generic price of about $40 per person per year across 120 countries. Access must be designed from the start, not added later.

011

Unitaid @unitaid.bsky.social · 16/07/2026

One in three people with a fever in malaria-endemic countries seek care from private providers. A new Unitaid report highlights gaps in private sector malaria care and calls for stronger integration into national systems to improve quality, surveillance and treatment outcomes.

000

Unitaid @unitaid.bsky.social · 15/07/2026

When essential health services come under pressure, partnerships help keep progress moving. GiveWell is investing US$5M in SAFEStart+, building on Unitaid’s work to expand access to testing for HIV, syphilis, hepatitis B and Chagas disease. Read more: ow.ly/26tq50ZnFVB

000

Unitaid @unitaid.bsky.social · 15/07/2026

Innovation creates impact when it works for the people delivering care. From training to integration into health systems, access is about more than introducing a new tool. It's about helping health workers deliver better outcomes every day.

000

Unitaid @unitaid.bsky.social · 14/07/2026

Before 2016, nearly half of all people living with HIV globally did not know their status. Today, HIV self-testing is part of national policy in 109 low- and middle-income countries. When barriers are removed, access can expand rapidly.

011

Unitaid @unitaid.bsky.social · 13/07/2026

“When new tools become available, countries shouldn't have to wait months before they can use them.” Unitaid is investing up to US$3.4M to help prepare for rapid access to promising Bundibugyo Ebola diagnostics and therapeutics if proven safe and effective.

000

Unitaid @unitaid.bsky.social · 13/07/2026

Every mother and newborn deserves access to care that can prevent infections. Ahead of #WorldHepatitisDay, join Unitaid, PATH, ICWEA and World Hepatitis Alliance, to discuss how triple elimination of HIV, syphilis and hepatitis B can help protect families. ow.ly/7j7K50ZmOHj

020

Unitaid @unitaid.bsky.social · 13/07/2026

A health innovation only changes lives if people can access it. Too often, cost, supply challenges, regulatory delays and limited awareness stand in the way. For 20 years, Unitaid has worked across every step of the access journey to turn innovation into impact.

100

Unitaid @unitaid.bsky.social · 09/07/2026

000

Unitaid @unitaid.bsky.social · 09/07/2026

For years, children with HIV were given bitter syrups or crushed adult tablets. Today, child-friendly medicines are making treatment simpler and more effective. Because children deserve medicines designed for them.

131

Unitaid @unitaid.bsky.social · 08/07/2026

When a mother survives childbirth, the impact goes far beyond the delivery room. Over 700 women die each day from preventable causes in pregnancy and childbirth. In Nigeria, earlier detection helped reduce deaths by 75%. This is access in action: systems saving lives.

000

Unitaid @unitaid.bsky.social · 06/07/2026

Malaria once meant fear and repeated illness for Bashir’s family. Today, his youngest daughter is protected by tools that didn’t exist a decade ago. Progress is real, but fragile. We must sustain access to stay ahead of malaria.

000

Unitaid @unitaid.bsky.social · 03/07/2026

Last night in Paris, we marked Unitaid’s 20th anniversary with partners from across the global health community. A moment to reflect on two decades of collaboration to expand access to health innovation worldwide.

000

Unitaid @unitaid.bsky.social · 03/07/2026

Across 20 years, we have helped introduce 150+ health products in 100+ countries. 390M people reached annually 46:1 return on investment US$10B savings in health system savings by 2030 86M illnesses averted Impact happens when access is built in from the start.

110

Unitaid @unitaid.bsky.social · 03/07/2026

HIV progress is clear: self-testing in 109 countries, 87% know their status, 89% on treatment. But none of this happened by chance. It is the result of sustained collaboration to turn innovation into access. Explore more from the report.

141

Unitaid @unitaid.bsky.social · 02/07/2026

This week in Paris, Unitaid’s Executive Board meets at a pivotal moment for global health. As we mark 20 years, board members are reflecting on progress, future priorities, and how innovation can continue to deliver impact at scale in a changing world.

001

Unitaid @unitaid.bsky.social · 02/07/2026

20 years of progress: • 150+ health solutions scaled • 390M people reached annually But the real story is simple: innovation only matters when people can access it. See what 20 years of access has made possible: 20years.unitaid.org

032

Unitaid @unitaid.bsky.social · 30/06/2026

Innovation is transforming global health. But impact depends on access. This week, we begin sharing stories from 20 years of progress, showing what happens when health tools reach the people who need them. More to follow.

010

Unitaid @unitaid.bsky.social · 26/06/2026

At the #HLM2026AIDS, one message was clear: ending AIDS by 2030 is possible, but only if innovation reaches everyone who needs it. The Political Declaration reinforces this commitment. The tools exist. Now we must make them affordable, accessible and available at scale for all.

010

Unitaid @unitaid.bsky.social · 24/06/2026

Lenacapavir, a twice-yearly HIV prevention injection, is a major advance, but impact depends on reaching people not routinely found in health facilities. In Zambia, a Unitaid-funded project is testing community delivery models. Read more below.

121

Unitaid @unitaid.bsky.social · 23/06/2026

Why do so many health innovations fail to reach the people who need them? At #HLM2026AIDS, Unitaid's Director of Strategy Janet Ginnard highlighted the gap between innovation and delivery, where access is often lost. The task now is to close it with systems that deliver at scale.

000

Unitaid @unitaid.bsky.social · 22/06/2026

Global leaders are in New York for the #HLM2026AIDS to reflect on progress and renew commitments to end AIDS. For 20 years, we have helped accelerate access to HIV prevention, diagnostics and treatment. Progress is real but uneven, with gaps in access and equity.

010